Home Launches

Launches

Emcure launches world’s first generic Eribulin for treatment of metastatic breast cancer

Eribulin will be available in India at approximately 40% cost of the innovator brand Bengaluru, April 3, 2019: Emcure Pharmaceuticals, a leading integrated global pharmaceutical company from India today announced the launch of the world's...

Lupin launches Testosterone Gel

New Delhi, April 15, 2019: Testosterone GelMumbai, Baltimore, April 12, 2019: Pharma major Lupin Limited (Lupin) announced the launch of Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation), having received an approval from the United States Food and Drug...

The Farm at San Benito Launches Brand New Aesthetic Center

New Delhi, April 06, 2019: In an effort to widen its range of healthcare and beauty services and solutions, The Farm at San Benito has launched a brand new Aesthetic Center in partnership with the renowned European Wellness...

Lupin launches Fluoxetine Tablets USP

Mumbai, April 10, 2019: Pharma major Lupin Limited (Lupin) announced the launch of Fluoxetine Tablets USP, 60mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Fluoxetine Tablets USP, 60mg, is the generic version...

Dr. Reddy’s Laboratories launches Tadalafil Tablets USP in the U.S. Market

Hyderabad, March 28, 2019: Dr. Reddy’s Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE: RDY), along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Tadalafil Tablets USP, a therapeutic equivalent generic version...